Pfizer
PFE
PFE
2,860 hedge funds and large institutions have $105B invested in Pfizer in 2024 Q2 according to their latest regulatory filings, with 212 funds opening new positions, 1,175 increasing their positions, 1,237 reducing their positions, and 171 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
5% less repeat investments, than reductions
Existing positions increased: 1,175 | Existing positions reduced: 1,237
1.15% less ownership
Funds ownership: 67.09% → 65.94% (-1.2%)
40% less call options, than puts
Call options by funds: $2.36B | Put options by funds: $3.89B
Holders
2,860
Holding in Top 10
32
Calls
$2.36B
Puts
$3.89B
Top Buyers
| 1 | +$352M | |
| 2 | +$340M | |
| 3 | +$237M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$221M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$203M |
Top Sellers
| 1 | -$686M | |
| 2 | -$444M | |
| 3 | -$318M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$225M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$224M |